We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LVWR.WS icon
8701
LiveWire Group Warrants
LVWR.WS
$8.45M
$886 ﹤0.01%
4,661
+4,629
+14,466% +$1.1K
EVGR
8702
DELISTED
Evergreen Corporation Class A Ordinary Share
EVGR
$884 ﹤0.01%
77
-4
-5% -$46
WTMA
8703
DELISTED
Welsbach Technology Metals Acquisition Corp. Common Stock
WTMA
$876 ﹤0.01%
+79
New +$868
GLDG
8704
GoldMining Inc
GLDG
$178M
$875 ﹤0.01%
979
CLST icon
8705
Catalyst Bancorp
CLST
$69.1M
$869 ﹤0.01%
75
-522
-87% -$6.1K
AEMD icon
8706
Aethlon Medical
AEMD
$1.75M
$863 ﹤0.01%
22
+20
+1,000% +$1.58K
MFEM icon
8707
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF
MFEM
$141M
$859 ﹤0.01%
42
-40
-49% -$799
AUUDW
8708
DELISTED
Auddia Inc Warrants
AUUDW
$845 ﹤0.01%
13,197
+13,181
+82,381% +$681
BLRX
8709
BioLineRX
BLRX
$12.3M
$844 ﹤0.01%
37
-277
-88% -$7.44K
PCGG icon
8710
Polen Capital Global Growth ETF
PCGG
$5.83M
$844 ﹤0.01%
76
-1,347
-95% -$14.7K
PSMR icon
8711
Pacer Swan SOS Moderate April ETF
PSMR
$90.7M
$842 ﹤0.01%
+32
New +$820
PBBK
8712
DELISTED
PB Bankshares
PBBK
$838 ﹤0.01%
+61
New +$781
WATT icon
8713
Energous
WATT
$77.6M
$827 ﹤0.01%
25
-89
-78% -$3.86K
VETZ icon
8714
Academy Veteran Bond ETF
VETZ
$110M
$820 ﹤0.01%
+41
New +$813
PRLHW
8715
DELISTED
Pearl Holdings Acquisition Corp Warrant
PRLHW
$820 ﹤0.01%
20,499
+7,900
+63% +$450
HGBL icon
8716
Heritage Global
HGBL
$40.3M
$819 ﹤0.01%
333
-1,379
-81% -$3.33K
NMAD
8717
Nomad Power Solutions
NMAD
$81.9M
$818 ﹤0.01%
+345
New +$964
SAGP icon
8718
Strategas Global Policy Opportunities ETF
SAGP
$79M
$815 ﹤0.01%
30
-160
-84% -$4.33K
BRLSW icon
8719
Borealis Foods Inc Warrant
BRLSW
$809 ﹤0.01%
11,901
+7,207
+154% +$642
CSCI
8720
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$809 ﹤0.01%
+183
New +$1.4K
HGTY.WS
8721
DELISTED
Hagerty, Inc. Warrants, each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share
HGTY.WS
$800 ﹤0.01%
+390
New +$744
CCIXU
8722
DELISTED
Churchill Capital Corp IX Unit
CCIXU
$799 ﹤0.01%
+79
New +$799
FTXH icon
8723
First Trust Nasdaq Pharmaceuticals ETF
FTXH
$56.4M
$790 ﹤0.01%
+29
New +$777
ENZ
8724
DELISTED
Enzo Biochem, Inc.
ENZ
$788 ﹤0.01%
723
+445
+160% +$501
FBYD icon
8725
Falcon's Beyond
FBYD
$487M
$785 ﹤0.01%
+90
New +$754

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.